Nuveen Churchill Direct Lending Corp. NCDL 深 滬
已收盤 09-05 16:00:00 美东时间
15.96
-0.050
-0.31%
華盛通- 最 高16.1784
- 今 開16.05
- 成交量 8.74万股
- 最 低 15.85
- 昨 收 16.01
- 總市值 8.27亿
- 52周最高 17.27
- 市盈率 靜 7.43
- 換手率 0.17%
- 52周最低 13.76
- 委 比 -50.00%
- 總股本 5180.71万
- 歷史最高 17.11
- 量 比 0.94
- 振 幅 2.05%
- 歷史最低 12.9001
- 每 手 1
- 風險率 0.60%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nuveen Churchill Direct Q2 EPS $0.46 Misses $0.48 Estimate, Sales $53.13M Miss $54.41M Estimate
Nuveen Churchill Direct (NYSE:NCDL) reported quarterly earnings of $0.46 per share which missed the analyst consensus estimate of $0.48 by 3.56 percent. This is a 19.3 percent decrease over earnings of $0.57 per share
08-06 19:22
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
UBS Maintains Neutral on Nuveen Churchill Direct, Raises Price Target to $17.5
UBS analyst Vilas Abraham maintains Nuveen Churchill Direct (NYSE:NCDL) with a Neutral and raises the price target from $16.5 to $17.5.
07-16 23:34
美股大行评级 | 潜在涨幅390.8%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
多家机构首予Amrize买入评级，目标价53~62美元；HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级>>
06-25 08:39
JMP Securities Maintains Market Outperform on Nuveen Churchill Direct, Lowers Price Target to $18
JMP Securities analyst Devin Ryan maintains Nuveen Churchill Direct (NYSE:NCDL) with a Market Outperform and lowers the price target from $18.5 to $18.
06-24 22:12
Alpha Buying: What Insiders Are Buying in Private Credit Right Now — And Why It Matters
As private credit continues to gain traction in institutional portfolios and th...
06-13 02:53
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
Wells Fargo Maintains Equal-Weight on Nuveen Churchill Direct, Lowers Price Target to $14
Wells Fargo analyst Finian O'Shea maintains Nuveen Churchill Direct (NYSE:NCDL) with a Equal-Weight and lowers the price target from $15 to $14.
05-14 02:34
Nuveen Churchill Direct Lending Corp. reports Q1 results
Nuveen Churchill Direct Lending Corp. press release (NYSE:NCDL): Q1 Net investment income of $0.53 per share Total investment income of $53.59M, vs. $51.6M a year ago Net realized and unrealized loss ...
05-08 21:49
